Hereditary Demyelinating Diseases of the CNS

Hereditary demyelinating diseases of the central nervous systems are caused primarily due to inherited genetic conditions. Examples include Alexander, Canavan, and Pelizaeus-Merzbacher diseases. Here is the latest research.

December 30, 2020
Open Access

Evolution of Adrenoleukodystrophy Model Systems

Journal of Inherited Metabolic Disease
Roberto MontoroMarc Engelen
January 14, 2021
Open Access

Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease

Translational Gastroenterology and Hepatology
Pankaj PrasunKimihiko Oishi
December 29, 2020

Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review

Multiple Sclerosis and Related Disorders
Paul M ElsberndDean M Wingerchuk
January 15, 2021
Open Access

Renal Denervation Ameliorates Cardiomyocyte Apoptosis in Myocardial Ischemia-reperfusion Injury

Zheng ZhaoYiyao Jiang
December 18, 2020

Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

Neuropathology and Applied Neurobiology
Pol Andrés-BenitoIsidro Ferrer
December 29, 2020
Open Access

Whitening effect of novel peptide mixture by regulating melanosome biogenesis, transfer and degradation

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Eung-Ji LeeEun Mi Kim
December 15, 2020

Clinical evaluation of childhood cerebral adrenoleukodystrophy with balint's symptoms

Brain & Development
Kazuo KubotaNobuyuki Shimozawa
January 17, 2021

Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed

European Journal of Internal Medicine
Eirini I RigopoulouGeorge N Dalekos
January 15, 2021

GRK2 mediates β-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis

Journal of Virology
Colleen L MayberryMelissa S Maginnis
January 9, 2021

Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk

Advances in Experimental Medicine and Biology
Marc FransenPaul P Van Veldhoven
January 5, 2021
Open Access

Targeted Metabolomics Identifies Differential Serum and Liver Amino Acids Biomarkers in Rats with Alcoholic Liver Disease

Journal of Nutritional Science and Vitaminology
Chenze ShiTao Wu
January 7, 2021
Case Report
Open Access

The Role of Non-Selective TNF Inhibitors in Demyelinating Events

Brain Sciences
Line Buch KristensenHelle H Nielsen

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved